Fingerprint
Dive into the research topics of 'A phase I trial of twice-weekly 17-allylamino-demethoxy-geldanamycin in patients with advanced cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase I trial of twice-weekly 17-allylamino-demethoxy-geldanamycin in patients with advanced cancer
Grzegorz S. Nowakowski, Andrea K. McCollum, Matthew M. Ames, Sumithra J. Mandrekar, Joel M. Reid, Alex A. Adjei, David O. Toft, Stephanie L. Safgren, Charles Erlichman
Research output: Contribution to journal › Article › peer-review
101
Scopus
citations